← Back to SBFM

Sunshine Biopharma Inc. - Common stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 13/05/2026Sep 2025Filed 13/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 13/05/2026Sep 2024Filed 13/11/2025Jun 2024Filed 12/08/2025Mar 2024Filed 15/05/2025
$9.3$8.1$9.4$9.4$8.9$8.4$9.3$7.5
−$1.6−$1.2−$0.9−$1.8−$1.2−$1.2−$0.5−$1.3
−$1.15−$0.25−$0.19−$0.82−$0.44−$0.94−$43.48−$2.00
1.44.94.63.62.71.3

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.